$12.41
4.83% yesterday
Nasdaq, Aug 18, 10:00 pm CET

Adaptive Biotechnologies Corp Stock price

$12.41
+2.02 19.44% 1M
+4.14 50.06% 6M
+6.42 107.01% YTD
+7.60 158.00% 1Y
+1.24 11.10% 3Y
-29.08 70.09% 5Y
-7.59 37.95% 10Y
-7.59 37.95% 20Y
Nasdaq, Closing price Mon, Aug 18 2025
-0.63 4.83%

Key metrics

Basic
Market capitalization
$2.0b
Enterprise Value
$1.9b
Net debt
positive
Cash
$197.9m
Shares outstanding
152.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
9.7 | 8.9
EV/Sales
9.4 | 8.6
EV/FCF
negative
P/B
11.0
Financial Health
Equity Ratio
37.6%
Return on Equity
-78.7%
ROCE
-29.9%
ROIC
-
Debt/Equity
0.7
Financials (TTM | estimate)
Revenue
$205.2m | $222.6m
EBITDA
$-110.1m | $-61.9m
EBIT
$-121.1m | $-128.3m
Net Income
$-121.2m | $-131.8m
Free Cash Flow
$-82.8m
Growth (TTM | estimate)
Revenue
21.6% | 24.4%
EBITDA
36.4% | 57.3%
EBIT
34.7% | 17.4%
Net Income
43.2% | 17.4%
Free Cash Flow
39.4%
Margin (TTM | estimate)
Gross
66.0%
EBITDA
-53.7% | -27.8%
EBIT
-59.0%
Net
-59.1% | -59.2%
Free Cash Flow
-40.4%
More
EPS
$-0.8
FCF per Share
$-0.5
Short interest
8.4%
Employees
619
Rev per Employee
$290.0k
Show more

Is Adaptive Biotechnologies Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,018 stocks worldwide.

Adaptive Biotechnologies Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Adaptive Biotechnologies Corp forecast:

12x Buy
86%
2x Hold
14%

Analyst Opinions

14 Analysts have issued a Adaptive Biotechnologies Corp forecast:

Buy
86%
Hold
14%

Financial data from Adaptive Biotechnologies Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
205 205
22% 22%
100%
- Direct Costs 70 70
9% 9%
34%
136 136
47% 47%
66%
- Selling and Administrative Expenses 159 159
2% 2%
78%
- Research and Development Expense 86 86
15% 15%
42%
-110 -110
36% 36%
-54%
- Depreciation and Amortization 11 11
11% 11%
5%
EBIT (Operating Income) EBIT -121 -121
35% 35%
-59%
Net Profit -121 -121
43% 43%
-59%

In millions USD.

Don't miss a Thing! We will send you all news about Adaptive Biotechnologies Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Adaptive Biotechnologies Corp Stock News

Positive
Seeking Alpha
11 days ago
Adaptive Biotechnologies and Netflix were top contributors, driven by strong earnings, momentum in core businesses, and positive outlooks. UnitedHealth Group and Visa detracted from performance due to earnings weakness, guidance cuts, and potential disruption from stablecoins. We initiated a position in HubSpot for its strong SMB positioning, AI-driven growth, and scalable financials, while exi...
Positive
The Motley Fool
12 days ago
Just after market close, Adaptive Biotechnologies (ADPT 5.97%) took the wraps off its second quarter. The following day, investors reacted to this by bidding the biotech company's stock up by almost 6%.
Positive
The Motley Fool
12 days ago
Adaptive (ADPT) Q2 Revenue Surges 36%
More Adaptive Biotechnologies Corp News

Company Profile

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA.

Head office United States
CEO Chad Robins
Employees 619
Founded 2009
Website www.adaptivebiotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today